Exam 2 - Sleep Disorders

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/47

encourage image

There's no tags or description

Looks like no tags are added yet.

48 Terms

1
New cards

Learning Objectives

  • Describe disease states on sleep

  • Recommend non-pharmacological approaches for managing insomnia

  • Evaluate the efficacy and potential adverse effects of medications used to treat insomnia

  • Apply an insomnia treatment algorithm to select an appropriate agent based on patient characteristics

  • Explain the diagnostic and treatment principles for narcolepsy and restless legs syndrome


2
New cards

What sleep related disorders are discussed in this lecture?

  • Insomnia → Inability to initiate/maintain sleep

  • Narcolepsy → Excessive & uncontrollable daytime sleepiness

  • Restless Leg Syndrome (RLS)

    • Urge to move legs

    • Associated with unpleasant sensations


3
New cards

What are the four stages of sleep?

NREM 1

NREM 2

NREM 3

REM

4
New cards

What are good sleep habits to counsel patients on?

  • Regular bedtimes & awakenings

  • Go to bed when sleepy

  • Sleep long enough to avoid feeling tired, but no more

  • Optimize the bedroom conditions

  • Develop a bedtime ritual to unwind

  • Do not stay in bed more than 15–20 minutes when unable to sleep

  • Avoid eating, caffeine, exercise prior to bed


5
New cards

How is insomnia defined?

  • Inability to initiate or maintain sleep despite adequate time and opportunity for sleep

    • Falling asleep (sleep onset/initiation)

    • Staying asleep (sleep maintenance)

    • Nonrestorative sleep

    • Results in daytime impairment


6
New cards

What are factors related to insomnia?

  • Pain

  • Psychiatric disorders

    • Depression, anxiety

  • Substance abuse/use

  • Medications

    • SSRIs

    • Stimulants

    • Glucocorticoids

    • Opioids


7
New cards

How is cognitive behavioral therapy (CBT) used in insomnia?

  • Multicomponent approach

    • Sleep education and sleep hygiene advice

    • Stimulus control and sleep restriction

    • Cognitive psychotherapy


8
New cards

Which medications are used for insomnia?

  • Nonbenzodiazepine hypnotics

    • Also known as the “Z-hypnotics”

  • Melatonin receptor agonist

  • Orexin receptor antagonists (DORAs)

  • Benzodiazepines (BZD)

  • Antihistamines

  • Antidepressants*

  • Antipsychotics*

*off label

9
New cards

What is the MOA of nonbenzodiazepine hypnotics?

  • Bind selectively to the GABAA receptor and enhance the inhibitory action of GABA in the CNS

    • Binds to omega-1

    • Minimally to omega 2 & 3 benzodiazepine receptors


10
New cards

What are advantages of using nonbenzodiazepine hypnotics?

  • Less cognitive, memory and motor side effects

  • Shorter half-life

  • Less hangover effects

  • Less tolerance, addiction potential, withdrawal symptoms than with BZD


11
New cards

Which nonbenzodiazepine hypnotics are used?

  • Eszopiclone (Lunesta) → Onset + maintenance

  • Zaleplon (sonata) → Onset only

  • Zolpidem (Ambien) → Onset + maintenance

    • Zolpidem XR

    • Zolpidem fasting-acting (Intermezzo)


12
New cards

What are AEs associated with nonbenzodiazepine hypnotics?

  • Headache

  • Drowsiness

  • Dizziness

  • Severe allergic reaction (anaphylaxis and facial swelling)

  • Beer's list: BZD and Z-hypnotics → avoid in elderly


Unpleasant metallic taste with Eszopiclone

13
New cards

What rare warning is aassociated with nonbenzodiazepine hypnotics?

Somnambulism/confused behaviors (5%)

  • May occur w/ all prescription sleep meds

    • driving, talking on phone, eating

    • behaviors while under influence meds with no memory of the events

    • anterograde amnesia

    • more likely if used w/ EtOH


14
New cards

What kind of medication is Ramelteon (Rozerem)?

Melatonin Receptor agonist

15
New cards

What is Ramelteon’s MOA?

  • Melatonin receptor agonist in the suprachiasmatic nucleus (SCN)

    • SCN is located above optic chiasm in hypothalamus

    • Regulates sleep & circadian rhythm

  • High affinity for MT-1 and MT-2 receptors

    • MT-1 receptor regulates sleepiness

    • MT-2 receptor regulates circadian rhythm


16
New cards

What is Ramelteon’s (Rozerem) role in therapy?

  • Role in insomnia

    • Decrease sleep onset latency

    • Recommended for sleep-initiation

    • Not effective for sleep maintenance


No limitation on duration of use

No abuse liability, non-scheduled by DEA

No evidence of dependence or tolerance

17
New cards

What are AEs associated with Ramelteon (MRA)?

  • Well tolerated, even in the elderly

  • Dizziness, fatigue, rare cases of anaphylaxis & angioedema

  • Symptoms of hyperprolactinemia or reduced testosterone


18
New cards

How should Ramelteon be taken?

Take 30min before bedtime

Avoid hazardous activities after taking

Full benefits may take up to 3 weeks

19
New cards

Who should NOT take Ramelteon?

Avoid with hepatic impairment (moderate to severe)

May be considered in pts w/ substance abuse history

20
New cards

What are DORAs? What is their MOA and use in therapy?

Dual Orexin Receptor Antagonists (DORAs)

  • Orexin role

    • Hypothalamic neurotransmitter that stabilizes wakefulness and suppresses sleep-inducing pathways

  • DORAs MOA → Block orexin-1 and orexin-2 receptors (OX1R, OX2R) → reduce orexin signaling → promote sleep

  • FDA approved (C-IV ) for insomnia


21
New cards

What are benefits of using DORAs?

  • Decreased sleep latency

  • Increased sleep efficiency

  • Increased total sleep time


22
New cards

Which DORAs do we use?

  • Lemborexant (Dayvigo) — 5-10 mg

  • Suvorexant (Belsomra) — 10-20 mg

  • Daridorexant (Quviviq) — 25-50mg


All indicated for sleep onset/maintenance

23
New cards

What drug interactions do DORAs have?

Lemborexant → DIs with CYP3A4


Others have DI with CYP3A

24
New cards

What are benefits of using DORAs?

  • Not associated with tolerance, rebound insomnia, or withdrawal

  • Not on Beers criteria (can be considered in elderly-lowest dose)

    • but next day drowsiness is still an issue


25
New cards

What are AEs of using DORAs?

  • Somnolence: dose-dependent impairment in driving the morning after

  • Rare sleep paralysis & cataplexy-like symptoms

  • Abnormal dreams, dry mouth, fatigue


26
New cards

What is a contraindication of using DORAs?

Narcolepsy

27
New cards

Which sedative-hypnotic benzodiazepines are used in insomnia?

  • Estazolam → Used for sleep onset or maintenance of insomnia

  • Flurazepam → Sleep onset + insomnia

  • Tempazepam → Sleep onset + insomnia

  • Triazolam → Sleep onset only


28
New cards

What are issues of using BZDs for insomnia?

  • Tolerance

    • Works best for 2–4 weeks

    • Over time, may need higher doses for same effect

  • Dependence

    • Can develop with long-term use

    • Withdrawal symptoms: trouble sleeping, sensitivity to light/sound, tinnitus, rarely seizures

  • Residual daytime sedation

  • Rebound insomnia

  • Anterograde Amnesia

    • All BZDs appear to impair the acquisition and encoding of new information (anterograde amnesia) while under their influence

    • Caution when using benzodiazepines in the elderly

  • Can cause memory problems

  • Increase the risk of falls

  • Accumulate (w/ the long half-life drugs)


29
New cards

Which OTC products do we use as sleep aids?

1st Gen Antihistamines → crosses BBB into CNS and blocks H1 receptors causing drowsiness


Regular use is not recommended

  • To avoid rapid development of tolerance

  • Some data suggest that they do not maintain sedative efficacy beyond a few days to weeks

  • Associated with higher incidence of daytime sedation than short- or intermediate-acting BZDs


30
New cards

Who should we avoid Diphenhydramine use in?

  • Avoid in the elderly

    • Anticholinergic action can worsen cognitive function or other medical conditions (on Beers Criteria list)

  • Do not use with cholinesterase inhibitors used for Alzheimer’s disease

    • Diminution of desired therapeutic outcomes


31
New cards

What are potential adverse effects of Diphenhydramine?

  • Residual next-day sedation

  • Anticholinergic SEs


32
New cards

What is the role of sedating antidepressants in insomnia?

  • Often prescribed in absence of depression

  • Trazodone is common

  • Used more often for tx of insomnia than the FDA-approved hypnotics

    • Amitriptyline

    • Doxepin

    • Mirtazapine

  • Doxepin

  • Sedation from muscarinic and histaminic receptor blockade


33
New cards

Which antidepressant can be used to help patients stay asleep?

Doxepin (Silenor) → used for those who have trouble staying asleep

34
New cards

What is Trazodone’s role/use in insomnia?

  • Popular for managing insomnia due to SSRI antidepressant

  • Devoids abuse potential →

    • Usual dose required is lower than that used for depression

  • Can be effective for insomnia for a few days but

    • Efficacy has not been fully established through clinical trials

    • Some studies suggest similar efficacy compared to zolpidem during 1st week but comparable efficacy to placebo by the second week (due to tolerance)


35
New cards

What are antipsychotic med’s role in insomnia?

  • Not 1st-line and should only be used with appropriate indication (psychosis, agitation) but sometime prescribed off-label

  • Most commonly used are:

    • Quetiapine

    • Olanzapine

  • Sedation from muscarinic & histaminic receptor blockade


36
New cards

Why do/don’t we use antipsychotics?

Benefit/harm ratio is unfavorable

  • Weight gain, metabolic dysregulation, falls & cardiac mortality in elderly


37
New cards

Patient has diificulty FALLING asleep: What factors do we consider in the agent we choose?

  • If we want to avoid next-morning residual sedation with risk factors*

    • Ramelteon

      • *RFs = older age, cognitive dysfunction, opioid use

  • If avoiding next-morning residual sedation is NOT a priority:

    • DORA

    • Non-BZD hypnotics

    • Ramelteon


38
New cards

Patient has diificulty STAYING asleep: What factors do we consider in the agent we choose?

  • Patient has RFs (older age, cognitive dysfunction, opioid use)

    • DORAs

    • Doxepin (low-dose)

  • No RFs

    • DORA

    • Non-BZD hypnotics (eszopiclone, zolpidem)

    • Doxepin (low-dose)


39
New cards

What is narcolepsy? How is it diagnosed?

  • Excessive daytime sleepiness with irresistible “sleep attacks”

  • Some experience cataplexy (sudden loss of muscle tone triggered by emotions)

  • May have sleep paralysis and hallucinations


Diagnosis:

  • Clinical history + sleep studies

  • Mean sleep latency <8 minutes with ≥2 sleep-onset REM periods


40
New cards

What is the pathophysiology of narcolepsy?

  • Associated with loss of orexin in hypothalamus (neuropeptide that promotes wakefulness & suppress sleep-inducing neurons)

  • CSF shows undetectable/very low orexin levels


41
New cards

What is cataplexy in narcolepsy?

  • Sudden, transient episodes of muscle weakness or paralysis during wakefulness

  • Complete voluntary muscle loss

  • Triggered by strong emotions: laughter, excitement, anger, surprise

  • Instability in REM sleep regulation (due to loss of orexin signaling)

  • Lasts 1-2 min


42
New cards

Is there loss of consciousness in cataplexy?

No, unlike seizures, patients remain awake and aware during the episode

43
New cards

How do we treat narcolepsy?

  • Both preventive & pharmacologic

  • Take naps at regularly scheduled times throughout the day

  • Stimulants may be used (early in the day) to increase wakefulness

    • Modafinil/Armodafinil (1st-line)

    • amphetamines (2nd line)


44
New cards

What can be taken for cataplexy prophylaxis?

  • TCAs, Venlafaxine, or Duloxetine → Suppress REM sleep

  • Sodium oxybate


45
New cards

What is sodium oxybate?

  • Sodium salt of GHB, a naturally occurring CNS transmitter with sedative and anesthetic properties

  • C-III substance

  • Indicated for treatment of cataplexy or excessive daytime sleepiness

  • Formulations: oral solution & ER powder form


46
New cards

What is Oveporexton (Orzeyful)?

  • Indication: treatment of narcolepsy type 1 (narcolepsy with cataplexy) in adults.

  • Mechanism: Acts as an oral orexin receptor 2 agonist to restore missing orexin signaling in the brain.

  • Dosing: taken orally twice daily


47
New cards

What is restless leg syndrome?

  • The urge to move legs, often with uncomfortable sensations

  • Worse at rest or night, improves with movement


Etiology

  • Due to a dysfunction w/ dopamine in the brain’s basal ganglia circuits

  • Reduced CNS iron stores (treat w/ iron replacement)


48
New cards

Which medications can we use for restless leg syndrome?

  • Dopamine agonist: Ropinirole, Pramipexole

  • Gabapentinoids: Gabapentin, Pregabalin